QAS International
QAS International Quality Animal Solutions
Home About Products Events Our Team Careers

Trusted Quality, Proven Results

Each product is manufactured under strict WHO‑GMP guidelines and backed by scientific research.

PHARMAVAC PHA

Category: Birds Vaccine


Description

Inactivated trivalent vaccine for pigeons containing paramyxovirus type 1 (PPMV-1, strain 988M, ≥6.9 log₂ HI), pigeon herpesvirus 1 (PHV-1, strain V298/70, ≥38.1 EU), and fowl adenovirus type 8 (FAdV-8, strain M2/E, ≥24.7 EU). Provides triple protection against paramyxovirosis, herpesvirus infection, and adenovirus-associated diseases in pigeons.

Product Details

Product Name: PHARMAVAC PHA

Type: Inactivated Trivalent Viral Vaccine - Oil-Emulsion Injectable

COMPOSITION

Each dose (0.3 ml) contains:

  • Active Substances:
  • Inactivated Pigeon Paramyxovirus Type 1 (PPMV-1), strain 988M: ≥ 6.9 log₂ haemagglutination inhibition (HI) units
  • Inactivated Pigeon Herpesvirus 1 (PHV-1), strain V298/70: ≥ 38.1 enzyme immunoassay (EU) units
  • Inactivated Fowl Adenovirus Type 8 (FAdV-8), strain M2/E: ≥ 24.7 enzyme immunoassay (EU) units
  • Adjuvant: Oil emulsion (paraffin oil, sorbitan oleate, polysorbate 80)
  • Preservative: Thiomersal

DESCRIPTION

PHARMAVAC PHA is an inactivated trivalent oil-emulsion vaccine for the active immunization of pigeons against three major viral pathogens: paramyxovirus type 1 (PPMV-1), pigeon herpesvirus 1 (PHV-1), and fowl adenovirus type 8 (FAdV-8) .

Pigeon Paramyxovirus Type 1 (PPMV-1) is an antigenic and host variant of the Newcastle Disease Virus (NDV) that causes severe neurological signs, diarrhea, and high mortality in pigeons

Pigeon Herpesvirus 1 (PHV-1) causes respiratory distress, conjunctivitis, and immunosuppression, predisposing birds to secondary infections

Fowl Adenovirus Type 8 (FAdV-8) has been increasingly recognized as a significant pathogen in pigeons, associated with inclusion body hepatitis and other systemic diseases . This trivalent vaccine provides comprehensive protection against these three important viral diseases affecting pigeon health and performance .

INDICATIONS

PHARMAVAC PHA is indicated for the active immunization of pigeons to:

  • Reduce mortality and clinical signs associated with paramyxovirus type 1 (PPMV-1) infection
  • Reduce mortality, clinical signs, and virus shedding associated with pigeon herpesvirus 1 (PHV-1) infection
  • Reduce clinical signs and mortality associated with fowl adenovirus type 8 (FAdV-8) infection

DOSAGE & ADMINISTRATION

Dosage:

  • 0.3 ml per pigeon, regardless of age or size
  • Each vial (17.5 ml) contains 50 doses

Route of Administration:

  • Subcutaneous injection in the dorsal region of the neck
  • Inject with a sterile needle, avoiding the head region

Preparation Before Use:

  • Warm the vaccine to room temperature (approximately +22°C) before administration
  • Shake the vial thoroughly before use and occasionally during administration
  • Use only clean, sterile syringes and needles
  • Use appropriately graduated syringes to ensure accurate dosing

Vaccination Schedule:

  • Primary Vaccination: One dose from 4 weeks of age
  • Booster Vaccination: A second dose is recommended 4 weeks after the primary vaccination to ensure optimal immunity
  • Onset of Immunity: 3 weeks after the booster dose
  • Duration of Immunity: 12 months after complete primary immunization
  • Annual Revaccination: All adult pigeons should be revaccinated annually

CONTRAINDICATIONS & PRECAUTIONS

  • Do not vaccinate unhealthy birds - only healthy pigeons should be vaccinated
  • Avoid accidental self-injection - the oil adjuvant may cause adverse reactions in humans
  • Do not freeze - freezing destroys the vaccine emulsion
  • Use within 4 hours after broaching - discard any unused vaccine after this time
  • Keep out of reach of children
  • Do not use after the stated expiry date
  • Administer under standard aseptic conditions

ADVERSE REACTIONS

  • A small, temporary swelling may develop at the injection site, which typically resolves within a few weeks
  • No significant depression of spirit, appetite, or flying ability has been reported
  • If adverse reactions occur, consult a veterinarian

WITHDRAWAL PERIOD

  • Meat: Zero days - no withdrawal period required
  • The vaccine does not leave harmful residues in meat products

STORAGE

  • Store refrigerated at 2°C - 8°C (36°F - 46°F)
  • Do not freeze - freezing inactivates the vaccine
  • Protect from light
  • Store in a dry place
  • Keep container tightly closed when not in use
  • Shelf-life: 18 months from manufacturing date when stored properly

Target Species: Pigeons (from 4 weeks of age)

Pack Sizes: 17.5 ml glass vial (50 doses)

PRODUCT SUMMARY
PHARMAVAC PHA Vaccine Inactivated Trivalent Vaccine Inactivated pigeon paramyxovirus type 1 (PPMV-1), strain 988M ≥6.9 log₂ HI; Inactivated pigeon herpesvirus 1 (PHV-1), strain V298/70 ≥38.1 EU; Inactivated fowl adenovirus type 8 (FAdV-8), strain M2/E ≥24.7 EU per 0.3 ml dose All Birds 17.5 ml (50 doses)

FOR VETERINARY USE ONLY

At QAS, we prioritize the safety and confidentiality of your personal and payment information. We implement industry-standard encryption protocols to ensure secure transactions and protect sensitive data.

QAS offers fast and reliable delivery of all medical products. Orders are processed and dispatched within 24-48 hours. We offer tracking options and work with trusted logistics partners to ensure timely delivery to your location.

If you're not completely satisfied with your purchase, QAS offers a 30-day return policy. Products must be unused, unopened, and in original packaging. Please contact our customer service team for assistance with returns and refunds.